Data presentations include review of the VE303 Phase 2 CONSORTIUM study, in which VE303 was well tolerated and highly active at preventing Clostridioides difficile infection recurrence in subjects at high risk of recurrence Further CONSORTIUM study analysis shows that the VE303 high dose led to more robust colonization, which in turn correlated with prevention of … [Read more…]
Proceeds to Enable Commercialization and Scale-Up of Unique RNA Sequencing Technology LAUSANNE, Switzerland–(BUSINESS WIRE)–Alithea Genomics, a fast-growing, emerging leader in the field of RNA sequencing and transcriptomics analysis, announced today the closing of a CHF 1 million seed financing round led by the Novalis Biotech Acceleration fund, with participation of Swiss-based private investors. Alithea has … [Read more…]
Granted by the United States Patent and Trademark Office, with extensions filed globally, the patent covers an approach that gives laboratories the ability to increase productivity for time and cost efficiencies. GOTHENBURG, Sweden–(BUSINESS WIRE)–#Biosero–Biosero, Inc., a BICO company and developer of laboratory automation solutions to orchestrate scientific discoveries, announced the issuance of a key patent … [Read more…]
OXFORD, England–(BUSINESS WIRE)–Beckley Psytech, a private company dedicated to addressing neurological and psychiatric disorders through the novel application of psychedelic medicines, has today announced the appointment of Dr. Laura Trespidi as Chief Development Officer. Dr. Trespidi brings more than 30 years’ of experience in global pharmaceutical and biotechnology companies, across clinical product development and manufacturing, … [Read more…]
Reducing headcount by 50% to further extend capital resources Cash runway extended to at least mid-2024 Cystic Fibrosis Program remains on track with initial readout from Phase 1b/2a study of BX004 expected in the third quarter of 2022 and readout from part 2 of the study expected in the first quarter of 2023 Atopic Dermatitis … [Read more…]
– Pivotal data on glofitamab, a potential first-in-class CD20xCD3 T-cell engaging bispecific antibody in heavily pre-treated patients with aggressive lymphoma, will be presented as part of our industry-leading hematology portfolio – – Further studies exploring broad genomic testing to support informed treatment decisions for patients and advance cancer care approaches will be presented – SOUTH … [Read more…]
NEW YORK–(BUSINESS WIRE)–DocGo (Nasdaq: DCGO), a leading provider of last-mile mobile health services and integrated medical transportation solutions, announced today that its Board of Directors has authorized a share repurchase program pursuant to which the Company may purchase up to $40 million of its Common Stock. “DocGo continues to revolutionize the delivery of healthcare, and … [Read more…]
Poster presentations on SNR1611, an experimental small molecule treatment for Alzheimer’s Disease, to be presented at Keystone Symposium on Neurodegeneration, June 5-9 Online abstract publication on GNUV201, a novel monoclonal antibody for cancer immunotherapy, at the American Society of Clinical Oncology Meeting, June 3-7 SEOUL, South Korea–(BUSINESS WIRE)–Genuv Inc., a clinical-stage biotechnology company focused on … [Read more…]
IntelliCentrics tech platform is uniquely positioned to transform how care is delivered, received and paid for through the company’s network of stakeholders across 10,000 locations of care including North America, Taiwan and the United Kingdom on a single technology platform. DALLAS–(BUSINESS WIRE)–IntelliCentrics (6819.HK) connects trusted stakeholders across the continuum of care by delivering valuable, technology-enabled … [Read more…]
Improving Air Purification Market Trends MOUNT VERNON, N.Y.–(BUSINESS WIRE)–Applied UV, Inc. (NasdaqCM: AUVI) (“Applied UV” or the “Company”), a pathogen elimination technology company that applies the power of narrow-range ultraviolet light (“UVC”) for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and automatically, announced its financial results for the … [Read more…]
